(Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has received lead clinical ... Our 2022 diabetes animal study DIAB-A22-1, utilizing ...
DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global ...
Listen to Story If you're struggling with weight loss and find that shedding those kilos feels like a constant nightmare despite your best efforts, you’re not alone ... Vidya also mentioned she hasn’t ...